Curcumin attenuates the organ dysfunction caused by endotoxemia in the rat

Nutrition

Volumn 24, Issue 11-12, 2008, Pages 1133-1138

  Memis, Dilek ^a   Hekimoglu, Sevtap ^a   Sezer, Atakan ^a   Altaner, Semsi ^a   Sut, Necdet ^a   Usta, Ufuk ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Curcumin; Experimental sepsis; Organ dysfunction

Indexed keywords

CURCUMIN; PLACEBO;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; GENERAL ANESTHESIA; HEPATITIS; LAPAROTOMY; LEUKOCYTE; LIVER CELL; MALE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RAT; SEPSIS; SMALL INTESTINE DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CURCUMIN; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ESCHERICHIA COLI; INTESTINE, SMALL; KIDNEY; LIVER; MALE; MULTIPLE ORGAN FAILURE; ORGAN SPECIFICITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; TREATMENT OUTCOME;

ANIMALIA; ESCHERICHIA COLI; RATTUS;

EID: 53449093510     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.06.008     Document Type: Article

References (30)

1. Abe Y., Hashimoto S., and Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39 (1999) 41-47
2. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Winokur P.L., Gales A.C., et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 29 (1999) 595-607
3. Wenzel R.P., Pinsky M.R., Ulevitch R.J., and Young L. Current understanding of sepsis. Clin Infect Dis 22 (1996) 407-413
4. Bochud P.Y., and Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326 (2003) 262-266
5. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283 (2002) G256-G265
6. Kaur G., Tirkey N., Bharrhan S., Chanana V., Rishi P., and Chopra K. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol 145 (2006) 313-321
7. Kono H., Asakawa M., Fujii H., Maki A., Amemiya H., Yamamoto M., et al. Edaravone, a novel free radical scavenger, prevents liver injury and mortality in rats administered endotoxin. J Pharmacol Exp Ther 307 (2003) 74-82
8. Matsuda H., Ishikado A., Nishida N., Ninomiya K., Fujiwara H., Kobayashi Y., and Yoshikawa M. Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica. Bioorg Med Chem Lett 8 (1998) 2939-2944
9. Luster M.I., Germolec D.R., Yoshida T., Kayama F., and Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19 (1994) 480-488
10. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 9 (2003) 161-168
11. Miquel J., Bernd A., Sempere J.M., Diaz-Alperi J., and Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34 (2002) 37-46
12. Chan M.M., Huang H.I., Fenton M.R., and Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55 (1998) 1955-1962
13. Bierhaus A., Zhang Y., Quehenberger P., Luther T., Haase M., Müller M., et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 77 (1997) 772-782
14. Jang M.K., Sohn D.H., and Ryu J.H. A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67 (2001) 550-552
15. Lukita-Atmadja W., Ito Y., Baker G.L., and McCuskey R.S. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 17 (2002) 399-403
16. Siddiqui A.M., Cui X., Wu R., Dong W., Zhou M., Hu M., et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ. Crit Care Med 34 (2006) 1874-1882
17. Lee J.J., Huang W.T., Shao D.Z., Liao J.F., and Lin M.T. Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 53 (2003) 367-375
18. Jobin C., Bradham C.A., Russo M.P., and Juma B. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163 (1999) 3474-3483
19. Feng S.H., and Lo S.C. Lipid extract of Mycoplasma penetrans proteinase K-digested lipid-associated membrane proteins rapidly activates NF-kappaB and activator protein. Infect Immun 67 (1999) 2951-2956
20. Franzoso G., Bours V., Park S., Tomita-Yamaguchi M., Kelly K., and Siebenlist U. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 24 (1992) 339-342
21. Gaddipati J.P., Sundar S.V., Calemine J., Seth P., Sidhu G.S., and Maheshwari R.K. Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19 (2003) 150-156
22. Sugino K., Dohi K., Yamada K., and Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 101 (1987) 746-752
23. Bautista A.P., Meszaros K., Bojta J., and Spitzer J.J. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 48 (1990) 123-128
24. Dunsmore K.E., Chen P.G., and Wong H.R. Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med 29 (2001) 2199-2204
25. Venkatesan P., and Rao M.N. Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues. J Pharm Pharmacol 52 (2000) 1123-1128
26. 2-induced renal epithelial (LLC-PK1) cell injury. Free Radic Biol Med 24 (1998) 49-54
27. Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., and Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 131 (2001) 2090-2095
28. Sugimoto K., Hanai H., Tozawa K., Aoshi T., Uchijima M., Nagata T., and Koide Y. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid induced colitis in mice. Gastroenterology 123 (2002) 1912-1922
29. Sharma R.A., Ireson C.R., Verschoyle R.D., Hill K.A., Williams M.L., Leuratti C., et al. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res 7 (2001) 1452-1458
30. Sharma R.A., Gescher A.J., and Steward W.P. Curcumin: the story so far. Eur J Cancer 41 (2005) 1955-1968